Início
Mercados
Gráficos e ideias
Algo
Notícias
Market
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Heatmap
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
PRLD
#3373
Prelude Therapeutics Incorporated
5.1
5
USD
+17.05%
Setor:
Cuidados de saúde
Base:
USD
Moeda do lucro:
USD
Faixa diária
Faixa anual
Mudança diária
+17.05%
Mudança mensal
+53.73%
Mudança em 6 meses
+278.68%
Mudança anual
+577.63%
Fechamento anterior
4.4
0
Abrir
5.1
9
Bid
Ask
Mínimo
4.8
5
High
5.2
1
Volume
242
Mercados
Ações
Cuidados de saúde
PRLD
Abrir gráfico completo
Financials
Visão geral
Relatórios
Estatísticas
Trimestral
Ano
Valor
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
42.3 M
43.6 M
43.74 M
43.75 M
48.23 M
179.32 M
Valuation ratios
Enterprise value
57.85 M
3.09 M
20.06 M
42.99 M
147.45 M
213.6 M
Price to earnings ratio
-0.76
-0.46
-0.5
-0.99
-2.25
-4.19
Price to sales ratio
13.81
—
—
—
18.38
—
Price to cash flow ratio
-0.94
-0.55
-0.57
-1.09
-3.96
-6.18
Price to book ratio
0.74
0.1
0.13
0.3
3.25
3.78
Enterprise value to EBITDA ratio
-0.42
—
—
—
-1.43
—
Profitability ratios
Return on assets %
-0.16
-0.23
-0.27
-0.21
-0.12
-0.82
Return on equity %
-0.22
-0.31
-0.41
-0.34
-0.24
-1.3
Return on invested capital %
—
—
—
—
-124.75
—
Gross margin %
100
—
—
100
100
—
Operating margin %
-845.78
—
—
-314.12
-307.59
—
EBITDA margin %
-833.55
—
—
-307.58
-300.18
—
Net margin %
-718.28
—
—
-303.46
-291.79
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
5.3
5.18
3.68
3.21
1.99
14.05
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.02
—
—
0.06
0.05
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.27
-0.45
-0.34
-0.25
0.3
-0.74
EBIT per share
-0.45
—
—
-0.27
-0.23
—
EBITDA per share
-0.44
—
—
-0.26
-0.22
—
Total debt per share
—
—
—
—
—
—
Cash per share
1.76
1.3
0.96
0.72
1.34
4.33
Net current asset value per share
1.79
1.35
1.01
0.77
1.37
4.5
Tangible book value per share
1.73
1.36
1
0.77
0.89
4.02
Working capital per share
1.45
1.09
0.74
0.53
0.68
3.04
Book value per share
1.73
1.36
1
0.77
0.89
4.02
Notícias
Prelude Therapeutics registra oferta de até US$ 25 milhões em ações por meio da Jefferies
Prelude Therapeutics files to offer up to $25 million in stock through Jefferies
Citizens eleva preço-alvo da Prelude Therapeutics com base no potencial do JAK2
Citizens raises Prelude Therapeutics price target on JAK2 potential
Ações da Prelude Therapeutics mantêm classificação de Superar o Mercado pela Citizens
Prelude Therapeutics stock gets reiterated Market Outperform rating at Citizens
Ações da Prelude Therapeutics disparam após FDA aprovar IND para medicamento contra câncer
Prelude Therapeutics stock surges after FDA clears IND for cancer drug
Tracking Baker Brothers Portfolio – Q3 2025 Update (NASDAQ:INCY)
Mizuho eleva classificação das ações da Incyte para Outperform após dados promissores do ASH
Prelude Therapeutics stock rating reiterated at Market Outperform by Citizens
Beat the Market the Zacks Way: Goldman Sachs, Micron, Prelude in Focus